載入...
Cost-Effectiveness of Buprenorphine–Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse
BACKGROUND: Not enough evidence exists to compare buprenorphine–naloxone with extended-release naltrexone for treating opioid use disorder. OBJECTIVE: To evaluate the relative cost-effectiveness of buprenorphine–naloxone versus extended-release naltrexone. DESIGN: Cost-effectiveness analysis alongsi...
Na minha lista:
| 發表在: | Ann Intern Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6581635/ https://ncbi.nlm.nih.gov/pubmed/30557443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M18-0227 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|